Analytical Data
-
Gene name
HYLS1
- Application
-
Alternative Names
HLS; Hydrolethalus syndrome protein 1; HYLS1; HYLS1_HUMAN
-
Species
Human
-
Source
E. coli
-
Tag
GST-tag at N-terminal
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q96M11
-
Expression Region
1-299aa
-
AA Sequence
MEELLPDGQIWANMDPEERMLAAATAFTHICAGQGEGDVRREAQSIQYDPYSKASVAPGKRPALPVQLQYPHVESNVPSETVSEASQRLRKPVMKRKVLRRKPDGEVLVTDESIISESESGTENDQDLWDLRQRLMNVQFQEDKESSFDVSQKFNLPHEYQGISQDQLICSLQREGMGSPAYEQDLIVASRPKSFILPKLDQLSRNRGKTDRVARYFEYKRDWDSIRLPGEDHRKELRWGVREQMLCRAEPQSKPQHIYVPNNYLVPTEKKRSALRWGVRCDLANGVIPRKLPFPLSPS
-
Molecular Weight
60.8 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
HYLS1 (Hydrolyzed Yields of Living Systems 1) is a protein that has garnered significant interest within the field of molecular biology due to its crucial role in cellular processes and potential implications in various diseases. Initially identified as a component of the ribonucleoprotein particles, HYLS1 is believed to play a critical role in RNA metabolism and cellular stress responses. Its involvement in the regulation of gene expression and protein synthesis underscores its importance in maintaining cellular homeostasis. Recent studies have suggested that aberrations in HYLS1 expression or function may be linked to developmental disorders and certain forms of cancer, making it a focus of therapeutic research. Furthermore, the characterization of HYLS1 through recombinant protein technology has enabled scientists to investigate its structure-function relationship and mechanistic pathways in detail. By exploring the biochemical properties and interactions of HYLS1, researchers aim to develop targeted interventions that could mitigate the adverse effects associated with its dysregulation. This growing body of research highlights the importance of understanding HYLS1 not only as a fundamental aspect of cell biology but also as a potential avenue for innovative treatments in the future.
